Breaking news ARCHES: Efficacy of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC) by disease characteristics
By: A. Alcaraz, Barcelona (ES)
Session: Plenary Session 5 BN Breaking news session
Location: Monday, 18 March 2019, 07:30 - 08:00, Red Area, eURO Auditorium 1